Plants emit insect-repelling chemical that could secretly be poisoning our air
In the 2008 film 'The Happening', plants turned against humans in an eerie twist of nature, releasing invisible neurotoxins that drove people to their deaths. It was pure sci-fi horror, but the idea that plants can chemically shape the world around them isn't fiction.
In fact, the air we breathe carries traces of a quieter kind of warfare — not against people, but pests. Scientists at Michigan State University have cracked a 40-year mystery around isoprene, a natural chemical that some plants emit to repel hungry insects. But there's a twist: while it defends the plant, it could be polluting the air.
Isoprene is a colorless, volatile hydrocarbon, a simple organic compound made up of five carbon atoms and eight hydrogen atoms (C₅H₈).
It's naturally released by certain plants, especially in hot weather, and is one of the most abundant hydrocarbons emitted into the atmosphere, second only to methane.
Unlike the fragrant terpenes you'd smell in pine forests or poplar groves, isoprene is odorless yet highly reactive. Once released, it interacts with sunlight and nitrogen oxides from vehicle exhaust and industrial emissions, contributing to the formation of ozone, aerosols, and other pollutants that degrade air quality.
'Everyone understands what it smells like when you walk through a pine forest,' Sharkey said. 'In an oak grove, which has more hydrocarbons because it makes so much isoprene, you just don't notice it.'
Until now, scientists weren't entirely sure why some plants go to the trouble of producing isoprene at all, especially since it doesn't seem to help them grow. But the new research suggests the answer lies in defense, not just against heat stress, but against hungry insects.
In controlled greenhouse experiments, MSU researchers grew two types of tobacco plants — one genetically modified to emit isoprene, the other left unchanged. When whiteflies invaded, they swarmed the non-emitting plants while avoiding the isoprene producers altogether.
Further tests using hornworms confirmed the pattern. Worms that fed on isoprene-rich leaves grew smaller and weaker than those that didn't. But it wasn't the isoprene itself that harmed them. Instead, the chemical triggered a spike in jasmonic acid, a defense hormone that disrupts an insect's ability to digest protein.
'The defense was not the isoprene itself, but the consequence of what isoprene did to the plant,' Sharkey said.
Another surprise came from soybeans. Long believed to have lost the ability to make isoprene through evolution, soybeans were found to release it in small bursts when their leaves were damaged. The discovery suggests they still carry the gene to produce isoprene and switch it only under stress.
Researchers say this discovery could change the way we protect crops. But that upside comes with a downside. Isoprene is a hydrocarbon that can worsen air pollution, especially in areas where air quality is already poor. If more crops are genetically modified to emit isoprene, it could further harm the atmosphere. The findings also raise concerns about how soybeans might be contributing to air pollution.
'That's one of the questions that's most important to come out of this research,' Sharkey said. 'Should we add isoprene to crop plants so that they're protected against insects and put up with their effect on the ozone? Or should we genetically engineer plants to turn off the isoprene synthase as much as we can to improve the atmosphere?'
The findings come from two new studies published in Science Advances and the Proceedings of the National Academy of Science.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
an hour ago
- Forbes
Trump Seeks Cuts To STEM Education, Emerging Technology Job Training
In its latest move to undercut university funding, the Trump administration is seeking to slash the ... More U.S. National Science Foundation budget in half, with a 75% cut to its STEM education funding. The agency has funded competitively won grants for scientific research and STEM education since 1950. Community college workforce programs will be implicated along the way. Congress is weighing options as it finalizes appropriations packages this summer. Just a few days after delivering his 100-day address at Macomb Community College in Warren, Michigan, President Donald Trump released a budget proposal that would slash funding for the U.S. National Science Foundation (NSF) by more than half. Its STEM education funding would be cut by 75%. For 75 years, the agency has played an indispensable role in funding STEM workforce training at America's community colleges — just like Macomb. Even though President Trump campaigned on supporting Americans economically and says he wants to boost our tech leadership, the administration is proposing to weaken one of the few avenues left to pursue the American dream through jobs of the future. Community colleges provide credentials that Americans can actually afford, often with a high return on investment — including meaningful salary improvements. NSF funding supports job training at community colleges in one of the global economy's key sectors: STEM, specifically the skilled technical workforce, which requires more education than a high school diploma but not necessarily a four-year degree. More than half of America's 37 million STEM workers are skilled technical workers who power our manufacturing, healthcare and aerospace industries and also are a bedrock of America's middle class. These workers earn more than their counterparts in non-STEM fields even when accounting for education levels. In addition, community colleges are poised to lead on one of the pressing technological issues of our time: artificial intelligence. NSF funding has enabled community colleges to create valuable AI education programs. Enrollment in Miami Dade College's AI program, for example, is already booming. Research we have done at New America including interviews with Miami Dade students has shown that these AI offerings are not just valuable to our youth but also to millions of working adults, including those with bachelor's degrees, who come back to community college to gain practical, industry-aligned skills. Under another NSF grant, Miami Dade has teamed with Houston Community College in Texas and the Maricopa Community College District in Arizona to launch a national consortium to scale AI education at community colleges nationwide, working alongside major employers like Microsoft and Google. Why put these essential training opportunities — and the students and employers who depend on them — at risk? Biotechnology is another emerging technology priority for President Trump and Congress that would be kneecapped by the proposed NSF cuts. Just last month, the Congressional National Security Commission on Emerging Biotechnology, chaired by Sen. Todd Young (R-IN), published a landmark report urging that the U.S. take action over the next three years to reaffirm its global leadership, and that we strengthen investments in biotech workforce education for the health of our citizens, our economy, and our military. The NSF has been leading innovation in biotechnology through community colleges for decades. Since its inception in 1992, its Advanced Technological Education program has invested more than $1.5 billion across more than half of the nation's over 1,200 community colleges, supporting training in automotive tech, cybersecurity innovation, textiles innovation, regenerative medicine, semiconductors, and beyond. When I joined Janet Spriggs, president of Forsyth Tech Community College, on Capitol Hill this year to discuss NSF funds for community college pathways to emerging industries, she made it clear that her institution's biotechnology impact would 'not be possible without NSF funding.' There is no substitute for these resources – not from philanthropy, industry or states. In fact, NSF funding is often seen as a seal of approval needed to convince other funders to make an investment. In the past year, the NSF has made pioneering co-investments in STEM workforce education with major companies including Intel, Micron and GlobalFoundries. Last fall, my own organization partnered with the NSF to launch a $3 million program supported by philanthropy to bolster community college training in emerging technologies relating to the NSF's Regional Innovation Engines grants. Authored under the CHIPS and Science Act, NSF Engines are the broadest investment in place-based, tech-driven economic growth since the Morrill Act created land-grant universities at the height of the Civil War. Skeptics may argue that community colleges can seek funding from other federal agencies. But New America tracks and studies many of those potential sources, and their structure, budget, and funding rules do not allow for the same support of cutting-edge technology education at community colleges. After all, the NSF is the agency charged by law with 'advancing all fields of science and engineering,' including undergraduate and graduate education, and it has an unmatched track record in this pursuit. Since Trump took office, Silicon Valley Venture capitalists, leading economists, politicians, tech executives such as Microsoft President Brad Smith, and leaders of local chambers of Commerce have warned that NSF cuts would hurt America's AI leadership, national security, startups, and economic growth. Adding to that list is our skilled technical workforce and the community colleges that prepare them for good jobs of today and tomorrow. Preserving the NSF and its budget should be a no-brainer, nonpartisan priority. The country's future looks bleaker without it.
Yahoo
an hour ago
- Yahoo
Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott's FreeStyle Libre® 3 Plus Sensor in the United States
Tandem continues to build its technology ecosystem to expand choice and personalization for people living with diabetes SAN DIEGO, June 20, 2025--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the Tandem t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology now works with Abbott's FreeStyle Libre® 3 Plus continuous glucose monitoring (CGM) sensor. The Company has initiated an early access program in the United States (U.S.), and intends to scale availability in the second half of 2025. "Diabetes management is not one-size-fits-all and it is critical for people living with diabetes to be able to personalize their AID systems to fit their unique healthcare and lifestyle needs," said Dr. Jordan Pinsker, chief medical officer of Tandem Diabetes Care. "The American Diabetes Association recommends AID systems as the preferred insulin delivery method in people with type 1 and other types of insulin-deficient diabetes, and this integration with Abbott's latest generation sensor allows even more CGM users to access the life-changing benefits of our Control-IQ+ technology." The FreeStyle Libre 3 Plus sensor has an extended 15-day wear time, transmitting automatic glucose readings every minute directly to the pump. This data is also available to view on the Tandem t:slim mobile app, providing users with multiple, convenient ways to access their current glucose trend. The t:slim X2 insulin pump is powered by Control-IQ+ technology, the latest generation of Tandem's advanced hybrid closed-loop algorithm, which adjusts insulin every 5 minutes based on predicted glucose values. It's the only system with the unique AutoBolus™ feature that calculates and delivers a correction bolus to help with missed meal boluses.* Control-IQ+ is easy to start, use, and personalize, and this latest integration works with the FreeStyle Libre 3 Plus sensor and extends its benefits to even more people with diabetes. "This is an exciting first step in our strategy to connect Tandem's portfolio of insulin pumps to Abbott's FreeStyle Libre 3 Plus sensors worldwide," said John Sheridan, president and chief executive officer of Tandem Diabetes Care. "We look forward to expanding access to our t:slim X2 users outside of the U.S. beginning later this year." When available, Tandem will email eligible users in the U.S. with more information.† About Tandem Diabetes CareTandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company's pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ+ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit Follow Tandem Diabetes Care on X @tandemdiabetes; use #tslimX2 #TandemMobi and # Tandem Diabetes Care on Facebook at Tandem Diabetes Care on LinkedIn at Forward Looking StatementsThis press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to, among other things, our ability to provide the software update for current t:slim X2 pump users and the t:slim X2 pumps pre-loaded with Freestyle Libre 3 Plus sensor integration software. These statements are subject to numerous risks and uncertainties, including our ability to sustain commercial scale manufacturing of the t:slim X2 pumps pre-loaded with Freestyle Libre 3 Plus sensor integration software, our ability to operate and maintain a system to facilitate online training for existing t:slim X2 pump customers upgrading their existing devices, and the risk that we may encounter other challenges that may delay the availability of the software update for current t:slim X2 pump users or the t:slim X2 pumps pre-loaded with Freestyle Libre 3 Plus sensor integration software. These and other risks are identified and described in greater detail under the "Risk Factors" heading of our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other documents filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Actual results could differ materially from those anticipated or projected in the forward-looking statements. Tandem undertakes no obligation to update or review any forward-looking statement in this press release because of new information, future events, or other factors. Important Safety Information – FreeStyle Libre SystemsProduct for prescription only; for Important Safety Information, please visit Important Safety Information – Tandem Diabetes CareRX ONLY. The t:slim X2 pump with interoperable technology (the pump) and Control-IQ+ technology (Control-IQ+) are intended for single patient use. The pump and Control-IQ+ are indicated for use with NovoLog or Humalog U-100 insulin. t:slim X2 insulin pump: The pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater. Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of Type 1 diabetes mellitus in persons 2 years of age and greater and of Type 2 diabetes mellitus in persons 18 years of age and greater. WARNING: Control-IQ+ should not be used in anyone under the age of 2 years old with Type 1 diabetes or under the age of 18 years old with Type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely. Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit for additional important safety information. © 2025 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, the Tandem logo, Control-IQ+, t:slim X2, t:slim, and Tandem Mobi are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. All other third-party marks are the property of their respective owners. * If glucose values are predicted to be above 180 mg/dL (or 10.0 mmol/L), Control-IQ technology calculates a correction bolus using the Personal Profile settings and a target of 110 mg/dL (or 6.1 mmol/L) and delivers 60% of that value. † Future updates for all or some Tandem products may not be developed and may not be offered everywhere and would be subject to applicable regulatory approvals. Software updates are only available to customers who are in warranty at the time they update their pump. Additional training may be required to access certain software updates. Charges may apply. Tandem may discontinue select software and features over time at its discretion. View source version on Contacts Media Contact: 858-366-6900media@ Investor Contact: 858-366-6900IR@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Gizmodo
an hour ago
- Gizmodo
New Study Backs Controversial Claim of 23,000-Year-Old Human Footprints in New Mexico
New research suggests the first Americans weren't who we thought they were. In 2021, researchers working in New Mexico published a paper that contributed to what remains one of the most controversial topics in American archaeology. The study describes human footprints in White Sands National Park dating to between 23,000 and 21,000 years ago, making them the oldest-known footprints in North America. This challenges long-held beliefs that the first North Americans were the Clovis people—named after artifacts found near Clovis, New Mexico—who arrived between 13,000 and 13,500 years ago during a relatively warm window near the end of the last Ice Age. Because footprints can't be directly dated, researchers estimated the age of these trace fossils—between 23,000 and 21,000 years old—by radiocarbon dating seeds found in the layers above and below the tracks. While critics continue to argue that the ancient seeds do not accurately represent the site's age, new research published earlier this week in the journal Science Advances adds further support to the original findings. As such, the seeds of the aquatic plant Ruppia cirrhosa are making another appearance at center stage in this debate. 'The issue of the arrival of the first Americans has long been contentious and the record from the White Sands locality generated considerable debate focused on the validity of the dating,' wrote the researchers in the new study, including University of Arizona archaeologist and geologist Vance Holliday, a co-author of the 2021 paper. 'This paper presents the results of an independent stratigraphic study with new associated dates, largely from a third source of radiocarbon that supports the initial dating.' In short, Holliday and his colleagues radiocarbon-dated new organic material, including Ruppia seeds, from new geological layers associated with the footprints. The team's new age estimate for the layers containing the footprints is between 23,000 and around 17,000 years ago, which overlaps with the original estimate of between 23,000 and 21,000 years ago. Radiocarbon dates of organic-rich sediments in one of the study areas, Gypsum Overlook, align more closely with the original estimate, yielding between around 22,400 years ago and 20,700 years ago. If the footprints are 23,000 years old, that means humans arrived in North America before the Last Glacial Maximum—when ice essentially created a barrier from the North Atlantic to the North Pacific coasts around 20,000 years ago. Even if the footprints are just 17,000 years old, that would still suggest that humans arrived in North America before the end of the last Ice Age around 11,700 years ago. 'This is a paradigm shift in the way we think about the peopling of the Americas, and human evolution more widely,' Nicholas Felstead, a researcher from Swansea University's Department of Geography who did not participate in the study, told Gizmodo in an email. 'This all but confirms multiple migration routes into the Americas, other than just the ice-free corridor around 14,000 years ago.' Early humans likely reached the Americas by island-hopping along the Bering Sea and Pacific coast, crossing the massive ice sheets of the Northern Hemisphere, or possibly drifting across the Pacific or Atlantic Oceans, Felstead explained. According to Karen Moreno, a paleobiologist at Austral University of Chile, the new research aligns with evidence from South American sites such as Monte Verde, Pilauco, Pedra Furada, and Arroyo del Vizcaino. The evidence from these sites suggest a human presence dating back 16,000 to 20,000 years ago, if not 30,000 years ago. 'South American evidence has certainly been overlooked, and I'm happy to know that North American work is finally pointing out to the direction our research in the South was supporting,' Moreno, who wasn't involved in the new study, told Gizmodo in an email. A study published in April, however, seems to call into question—once again—the validity of radiocarbon dating organic matter from the White Sands site. The main point of contention centers on what's known as the hard water effect. The effect occurs when aquatic plants like Ruppia draw carbon from groundwater, unlike terrestrial plants, which absorb carbon from the atmosphere, David Rachal, a geoarchaeologist with Vieja Consulting and a co-author of the April study, explained to Gizmodo in an email. The carbon in groundwater consists of very old dissolved limestone, which makes aquatic plants appear much older than they actually are in radiocarbon dating. As such, the hard water effect is 'baked in' to both the Ruppia seeds and other organic material from the mud layers in question, Rachal explained. 'According to their model, if the Ruppia grew within the site under these uniform-like conditions, shallow water, very well aerated, then the hard water effect is not a problem,' he said. Rachal and his colleague's model, however, indicates that the plant did not grow at the site, but rather washed into it. 'There's zero physical evidence that the plant grew within the site. And if it didn't grow within the site, the hard water effect is still there.' As such, any other samples that match the Ruppia seeds dates are also problematic, he added. Even without considering the hard water effect, 23,000-year-old footprints still raise more questions than it answers, according to Ben Potter, a University of Alaska Fairbanks anthropologist who also did not participate in the study. Namely, because they left no other known traces for 10,000 years. 'We need actual human-produced artifacts to understand the identity, behaviors, and potentially fate of these populations,' he told Gizmodo in an email. Ultimately, today's study represents the most recent volley in the highly contentious first-Americans debate. The ball is once again in the opposing side's court, and I'm sure their response will not take long.